Skip to main content

Table 3 Clinical and pathological characteristics of 33 patients with breast cancer

From: Accurate evaluation of axillary sentinel lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid in breast cancer: a preliminary clinical trial

 

No. of patients

Percentage

Age (years)

60.4 ± 13.2 (range 32–86)

 

Palpability

 Breast tumor

  Yes

22

68.8

  No

10

31.2

 ALN

  Yes

2

6.3

  No

30

93.7

Surgery

 Breast

  BCS

9

28.1

  MRM

23

71.9

 Axilla

  SLNB

19

59.4

  SLNB + AD

9

28.1

  AD

4

12.5

Laterality

 Right

11

34.4

 Left

21

65.6

Tumor size (mm)

21.9 ± 19.2 (6–115)

 

Multiplicity

 Yes

4

12.5

 No

28

87.5

T stage

 pTis

6

18.6

 pT1a

0

0

 pT1b

5

15.6

 pT1c

9

28.1

 ypT1c

3

9.4

 pT2

7

21.9

 ypT2

2

6.4

N stage

 0

21

65.6

 1mi

1

3.1

 1

10

31.3

Stage

 0

6

18.8

 IA

11

34.4

 IB

1

3.1

 IIA

7

21.9

 IIB

3

9.4

 IIIA

4

1.3

Histology

 IDC

23

71.9

 DCIS

5

15.6

 MUC

3

9.4

 SCC

1

3.1

  1. BCS breast conserving surgery, MRM modified radical mastectomy, SLNB sentinel lymph node biopsy, AD axillary dissection, IDC invasive ductal carcinoma, DCIS ductal carcinoma in situ, MUC mucinous carcinoma, SCC squamous cell carcinoma